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Previously, the purified recombinant 2A proteases (2Apro) of coxsackievirus B4 (CVB4) and human rhinovirus type 2 (HRV2)
were shown to cleave synthetic peptides derived from human or rabbit eIF4G as well as eIF4G protein purified from rabbit
reticulocytes. These results were in contrast to previous evidence which supported the view that eIF4G cleavage activity in
poliovirus-infected HeLa cells required a cellular factor(s) activated by poliovirus (PV) 2Apro. In the present study, recombi-
nant PV 2Apro was shown to cleave either rabbit or human eIF4G or their derived peptides in direct cleavage reactions, but
cleaved the 4G-derived peptides with 100-fold lower efficiency than with a peptide derived from the poliovirus polyprotein.
In these experiments, up to 25-fold molar excess of 2Apro over eIF4G protein was required to cause greater than 50%
cleavage. CVB4 2Apro was also tested in peptide cleavage assays under the same conditions as PV 2Apro and was found to
cleave all eIF4G substrates with efficiencies similar to PV 2Apro. Finally, cleavage reactions utilizing recombinant eIF4G
containing a G486E substitution at the cleavage site for CVB4 and HRV2 proteases resulted in drastically reduced cleavage
by PV 2Apro, similar to the reduction previously seen with HRV2 and CVB4 2Apro, confirming that all three viral 2A proteases
recognize the same cleavage site on eIF4G. These data show that PV 2Apro can directly cleave eIF4G in vitro with efficiencies
similar to those of CVB 2Apro, but cleavage efficiency of eIF4G is approximately 1000-fold lower than cleavage of a peptide
derived from the authentic 2A cleavage site on the poliovirus polyprotein. © 1998 Academic Press
INTRODUCTION
Enteroviruses and rhinoviruses are distinguished by their
ability to rapidly and efficiently inhibit protein synthesis from
cellular mRNAs in HeLa cells. The mechanism of this trans-
lational control is exerted partly through cleavage of the
eukaryotic protein synthesis initiation factor 4G (eIF4G; for-
merly known as p220 and eIF-4g) coincident with the shut-
off of host translation in poliovirus-infected HeLa cells
(Etchison et al., 1982). The eIF4 factors recruit ribosomes to
the m7GTP-containing cap structure found at the 59 end of
cellular mRNA. One complex of eIF4 factors that can be
isolated from mammalian cells consists of eIF4E, eIF4A,
and eIF4G and is termed eIF4F. Cleavage of eIF4G abol-
ishes eIF4F activity (Etchison et al., 1982, 1984) in cellular
translation initiation which can be restored by addition of
intact eIF4F (Grifo et al., 1983). This model of inhibition has
been called ‘‘host-cell shutoff’’ as it does not affect virus-
specific protein synthesis which occurs through a novel
cap-independent mechanism (Belsham and Sonenberg,
1996). Based on these observations, eIF4G proteolysis is
accepted as the hallmark of translational inactivation by
enteroviruses (Lloyd et al., 1988), rhinoviruses (Etchison
and Fout, 1985), and aphthoviruses (Kirchweger et al., 1994).
2A protease (2Apro) is known to be the only enteroviral
protein required for activation of the host translation shutoff
mechanism, since a poliovirus containing a single amino
acid insertion in the 2A region did not cause eIF4G cleav-
age or host translation shutoff (Bernstein et al., 1985). Fur-
thermore, expression of 2Apro in vitro or in vivo was suffi-
cient to cause eIF4G cleavage and host translation shutoff
(Davies et al., 1991; Kra¨usslich et al., 1987; Sun and Balti-
more, 1989). Despite the evidence that 2Apro induces eIF4G
cleavage, early experiments suggested that 2Apro did not
directly catalyze eIF4G cleavage in poliovirus-infected
HeLa cells. In these reports, the bulk of 2Apro did not
copurify in subcellular fractions of HeLa cells with the
eIF4G cleavage activity, which was measured in in vitro
assays (Lloyd et al., 1986). Furthermore, anti-2Apro antibody
which could block 2Apro activity in reticulocyte lysates was
unable to inhibit the eIF4G cleavage activity generated by
synthesis of 2Apro in vitro (Kra¨usslich et al., 1987) or the
eIF4G cleavage activity present in lysates from PV-infected
HeLa cells (Lloyd et al., 1986). Last, the eIF4G-specific
cleavage activity partially purified from poliovirus-infected
cells was found to be dependent on eIF3 for maximal
activity (Wyckoff et al., 1992), suggesting that complex in-
teractions of host proteins may be involved in the eIF4G
cleavage mechanism in vivo. These data support a model
involving a two-step mechanism whereby 2Apro activates a
cellular protease(s) which then cleaves eIF4G.
More recently, the hypothesis that 2Apro directly cleaves
eIF4G without a requirement for a cellular protease has
been advanced and tested in different experimental sys-
tems. The cloning and sequencing of human eIF4G cDNA
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(Yan et al., 1992) revealed the presence of at least three
potential recognition sites for enterovirus 2A proteases
based on known substrate recognition preferences (Hellen
et al., 1992; Sommergruber et al., 1992). Recombinant 2Apro
from coxsackievirus B4 (CVB4) and human rhinovirus type 2
(HRV2) was shown to catalyze direct cleavage of peptides
derived from rabbit or human eIF4G (Sommergruber et al.,
1994) or purified rabbit eIF4G (Lamphear et al., 1993; Liebig
et al., 1993). Furthermore, the cleavage site recognized by
CVB4 2Apro on rabbit eIF4G was mapped to the amino acid
pair Arg486 and Gly487 (Lamphear et al., 1993). This cleav-
age site corresponded with the eIF4G-derived peptide most
rapidly cleaved by CVB4 2Apro in separate experiments
(Sommergruber et al., 1994). These data suggested that
rhino- and enterovirus 2Apro may cleave eIF4G directly in
vivo, without the requirement for an intermediate cellular
factor.
In light of the disparate results obtained from the PV
versus CVB and HRV systems, it has been suggested
that PV uses a 2Apro-activated cascade mechanism
whereas CVB or HRV 2Apro directly catalyze eIF4G cleav-
age (Haller and Semler, 1995). It is therefore important to
clarify whether eIF4G proteolysis could be directly cata-
lyzed by poliovirus 2Apro, as described previously for
CVB4 and HRV2. Previously, this was not possible since
PV 2Apro, which is unlike CVB 2Apro in its biophysical
characteristics, displaying a hydrophobic nature and a
tendency to aggregate readily, could not be purified. We
have devised new methods to purify PV 2Apro which
enabled this hypothesis to be tested. The findings pre-
sented here show that the eIF4G protein or peptides
derived from it can serve as substrates for both PV 2Apro
and CVB4 2Apro, but they are cleaved inefficiently. This
result supports the conclusion that these viruses do
utilize a common mechanism for eIF4G proteolysis. How-
ever, the extremely low efficiency of direct cleavage by
2Apro suggests that a more efficient mechanism involving
a cellular factor may also be operative during entero- and
rhinovirus infection.
RESULTS
Amino acid sequence of peptide substrates used
in direct cleavage assays
The 1D2A junction regions in the polio-, coxsackie-,
and rhinovirus polyproteins contain several conserved
amino acids previously found to be important determi-
nants for cis cleavage (Table 1, boldface italic). In partic-
ular, the amino acids at the P2 and P19 positions were
shown to be important in PV (Hellen et al., 1992) and
HRV2 (Sommergruber et al., 1992). The dependence on
the amino acid at the P4 position for 2Apro enzymatic
efficiency was also demonstrated for CVB4 and HRV2
(Sommergruber et al., 1994). Peptides derived from the
CVB and HRV 2Apro cleavage site region in eIF4G contain
the same conserved residues (Table 1, boldface italic).
However, comparison of these sequences also reveals
significant differences between the viral and host se-
quences outside the three conserved positions. These
residues strongly influence the actual cleavage efficien-
cies of the 2Apro reaction (Hellen et al., 1992; Sommer-
gruber et al., 1994). For instance, the PV polyprotein
sequence is a poor substrate for cleavage by coxsack-
ievirus A21 (CVA21), HRV2, and HRV14 2Apro (Hellen et
al., 1992). The 1D2A peptide used in this study is identi-
cal to the native PV polyprotein sequence and was in-
cluded in the cleavage assays as a control for PV 2Apro
proteolytic activity.
HPLC analysis of direct cleavage assays
We took advantage of the unusual aggregation and
chromatographic properties of 2Apro to facilitate its puri-
fication. Figure 3A shows the highly enriched 2Apro frac-
tion (pool S) which was used in most experiments since
it could be prepared in larger quantities (lane a). Pool C
2Apro (lane b) contained no discernable contaminating E.
coli proteins and was only used for cleavage of human
eIF4G. In comparative eIF4G cleavage assays using
crude ribosomal salt wash fractions or purified com-
plexes, pool C and pool S preparations of 2Apro were
judged to be equally active; however, polyhistidine
tagged 2Apro (lane c), which required denaturation and
refolding for purification, was only approximately 10% as
active as the other 2Apro pools (data not shown).
Pool S PV 2Apro was first tested for its ability to cleave
the 1D2A and human eIF4G peptides. The results of
peptide cleavage assays are illustrated by the reverse-
phase HPLC chromatograms shown in Fig. 1. When in-
cubated with 1.0 nmol 2Apro (molar ratio of 1:400 (enzyme:
substrate)), the 1D2A peptide was completely processed,
as determined by the conversion of the original peak into
two peaks with shorter retention times (Fig. 1B). These
TABLE 1
Comparison of Viral Polyprotein Cleavage Sites
with Synthetic Peptide Substrates
Sourcea Sequenceb
PV1 polyprotein . . . STKNLTTY 2 GFGHQNKA . . .
CVB4 polyprotein . . . ERASLITT 2 GPYGHQSG . . .
HRV2 polyprotein . . . TRPIITTA 2 GPSDMYVH . . .
1D2A peptide STKNLTTY 2 GFGHQNKA
H-eIF4G peptide
(human sequence) GRTTLSTR 2 GPPRGGPG
R-eIF4G peptide
(rabbit sequence) GRPALSSR 2 GPPRGGPG
a For PV1 see Racaniello and Baltimore (1981); for CVB4 see Jenkins
et al., (1987); for HRV2 see Skern et al., (1985); for human eIF4G see Yan
et al., (1992); and for rabbit eIF4G see Lamphear et al., (1993).
b The symbol 2 denotes the scissile bond; conserved residues at
the P4, P2, and P19 positions are indicated by boldface italic letters.
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peptides were subsequently confirmed by electrospray
mass spectroscopy to be the expected products. This
indicates that the purified PV 2Apro enzyme preparation
used in this study was highly active. Surprisingly, when
the protease was combined with the eIF4G peptide at
the same concentrations of enzyme and peptide, no
detectable cleavage products were observed (Fig. 1D).
This result was obtained numerous times.
Comparative cleavage of peptide substrates
by poliovirus- and coxsackievirus 2Apro
Since cleavage of the eIF4G peptide was not ob-
served with the PV 2Apro, a series of additional cleav-
age assays was carried out at increasing enzyme
concentrations in an effort to determine if greater
amounts of PV (Fig. 2A) or CVB4 protease (Fig. 2B)
could catalyze detectable cleavage of the eIF4G-de-
rived substrates. Results of peptide cleavage assays
showed that over 90% of the 1D2A peptide was
cleaved by 1 nM PV 2Apro, but proteolysis of the human
and rabbit eIF4G peptides was below detectable limits
(Fig. 2). Cleavage of greater than 90% of either eIF4G-
derived peptide was only observed in reactions con-
taining at least 10 nM protease and reduced substrate
(40 nM). These data show that PV 2Apro can directly
cleave the 4G-derived peptides, as previously reported
for CVB4. However, compared to the highly efficient
cleavage of the 1D2A substrate, cleavage efficiency of
reactions containing eIF4G peptides was low.
CVB4 2Apro exhibited relatively poor cleavage of the po-
liovirus 1D2A peptide at the 1:400 ratio (Fig. 2B). This was
not unexpected due to primary amino acid sequence dif-
ferences flanking the viral 1D2A junctions and is similar to
previous reports of poor HRV2, CVB4, and CVA21 2Apro
activity on 1D2A substrates from different virus species
(Hellen et al., 1992; Sommergruber et al., 1994). CVB4 2Apro
cleaved 1D2A only at the higher molar ratios. The effect of
altering the concentrations of enzyme (up to 100 nM) and
substrate at fixed molar ratios was also examined and
found to increase cleavage by less than 2-fold for each
10-fold increase in concentration (data not shown). Further,
extension of incubation periods to 3 h resulted in only slight
enhancement of cleavage observed (typically 10%). More
importantly, the levels of cleavage of the eIF4G peptides
catalyzed by PV or CVB4 2Apro did not differ significantly
under equivalent assay conditions. Thus, for either pro-
tease, direct cleavage of eIF4G peptides was demon-
strated, but approximately 1:4 molar ratios of enzyme to
substrate were required.
Direct cleavage of eIF4G in eIF4F or eIF4F/eIF3
complexes by PV or CVB4 2Apro
It is possible that cleavage of peptide substrates does
not accurately reflect the mechanism by which eIF4G
protein is cleaved. To address this, we tested purified
eIF4G present in either eIF4F or eIF4F/eIF3 complexes
for its ability to serve as a substrate for direct cleavage
by each 2Apro. The eIF4F/eIF3 complex was chosen
since two reports suggest that eIF3-binding may alter the
conformation of eIF4G, thus facilitating eIF4G cleavage
FIG. 1. HPLC chromatograms of direct cleavage of poliovirus- or eIF4G-derived peptides by poliovirus 2Apro. Peptide cleavage reactions (30 ml) were
carried out as described under Materials and Methods and contained 20 mg of peptide and 0.5 mg of PV 2Apro (when present). Assays shown
contained (A) PV 1D2A peptide alone, (B) PV 1D2A peptide plus protease, (C) human eIF4G peptide alone, or (D) human eIF4G peptide plus protease.
Elution time is indicated in minutes.
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by a cellular protease (Wyckoff et al., 1990, 1992). A
similar effect may likewise enhance direct cleavage by
2Apro. Further, when eIF4G is bound in a complex with
eIF4E (also contained in eIF4F), direct cleavage by HRV
2Apro is enhanced by 100-fold over eIF4G alone
(Haghighat et al., 1996). Various concentrations of PV
2Apro (pool C) were incubated with the purified eIF4F
substrate, reaction products were analyzed on SDS–
PAGE, and eIF4G proteolysis was visualized by silver
staining. Figure 3B shows that no detectable accumula-
tion of eIF4G cleavage products was observed in reac-
tions containing 0.08–8.3 nM protease (1:400, 1:40, or 1:4
enzyme:substrate ratios, lanes b–d). In reactions contain-
ing 83 nM enzyme (2.5-fold molar excess of protease,
lane e), approximately 50% cleavage of human and rabbit
eIF4G was detected, demonstrating direct cleavage of
eIF4G by PV 2Apro for the first time. However, the direct
cleavage reaction was inefficient, since 830 nM enzyme
concentration (25-fold molar excess of protease) was
required to completely convert human eIF4G to cleavage
products (lane f). We also tested the ability of pool S 2Apro
to cleave eIF4G present in a cap-purified eIF4F/eIF3
complex and obtained essentially the same degree of
cleavage at each of the molar ratios shown (Fig. 3C).
Table 2 summarizes percentage cleavage obtained with
either pool C or pool S 2Apro using the two forms of
human eIF4G substrate and shows cleavage results to
be nearly equivalent. This suggests that the additional
presence of eIF3 in cleavage reactions does not signif-
icantly enhance the efficiency of eIF4G cleavage in vitro.
Similarly, CVB4 2Apro did not yield significant eIF4G
cleavage products in assays with molar ratios up to 1:4
(Table 2). When the CVB4 2Apro concentration was in-
creased to 25 or 250 nM, (2.5:1 or 25:1 molar ratio), the
amount of detectable proteolysis was similar to but
slightly lower than that for PV (Fig. 3D, Table 2). Previ-
ously published reports using CVB4 and HRV2 in direct
cleavage reactions also used high molar ratios, in gen-
eral agreement with the results presented here
(Haghighat et al., 1996; Lamphear et al., 1993; Liebig et
al., 1993). Experiments were also conducted using rabbit
eIF4F/eIF3 complexes as substrates. Both PV and CVB4
2Apro were found to be slightly less efficient at cleavage
of rabbit eIF4G than human eIF4G (Table 2). Additionally,
histidine-tagged PV 2Apro was found to be capable of
catalyzing some direct cleavage of eIF4G; however, over-
all protease activity of this fraction was poor, probably
due to inefficient renaturation (Table 2).
Direct cleavage of recombinant eIF4G
by PV or CVB4 2Apro
Previously, we showed that CVB4 and HRV2 2Apro
cleave human eIF4G at Arg485-Gly486 (Lamphear et al.,
1993) and that the rate of this cleavage is markedly
reduced when Gly486 is replaced with a glutamate res-
idue (Lamphear and Rhoads, 1996). It was therefore of
interest to determine if the cleavage of human eIF4G by
PV 2Apro is also influenced by this alteration of amino
acid sequence. We incubated in vitro synthesized eIF4G
(wt and G486E variant) with different amounts of PV
2Apro. Figure 4 shows the eIF4GG486E variant was signif-
icantly more resistant to proteolysis than eIF4Gwt. In-
creased resistance to cleavage was greater than 10-fold
based on the observation that the extent of cleavage of
eIF4GG486E by 1 mg of PV 2Apro was intermediate be-
tween that achieved with 0.01 and 0.1 mg of 2Apro on
eIF4Gwt. Although this resistance is less dramatic than
that observed with CVB4 2Apro, it is comparable to that
observed for HRV2 2Apro (Lamphear and Rhoads, 1996),
suggesting that PV 2Apro cleaves human eIF4G at the
same site as the other picornaviral proteases. However,
the yield of cpC was low relative to cpN and the initial
amount of intact eIF4G, contrary to what was observed
previously for HRV2 and CVB4 2Apro digestions (Lam-
phear and Rhoads, 1996). This suggests that cpC is less
FIG. 2. (A) Efficiency of direct cleavage of peptide substrates by
2Apro. PV 2Apro (A) or CVB4 2Apro (B) was used in equivalent reactions.
Cleavage of the PV 1D2A peptide (solid bars), human eIF4G peptide
(gray bars), or rabbit eIF4G peptide (open bars) was carried out at three
enzyme:substrate molar ratios as described under Materials and Meth-
ods. Peptide cleavage was quantitated as described under Materials
and Methods.
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stable in the presence of PV 2Apro and that secondary
proteolysis may occur subsequent to the primary cleav-
age at Arg485-Gly486.
DISCUSSION
Infection of HeLa cells by human enteroviruses and
rhinoviruses results in rapid cleavage of eIF4G which, in
the case of poliovirus, is generally complete by 2.5 h
postinfection. Two mechanisms for eIF4G cleavage,
which are not mutually exclusive, have been proposed
based on evidence from different experimental systems.
First, earlier studies showed that the eIF4G cleavage
activity measurable in PV-infected cells did not copurify
with the bulk of 2Apro, suggesting that viral infection
activated a cellular eIF4G-specific protease (Lloyd et al.,
1986). Second, and more recently, mixing experiments
with highly purified eIF4G and 2Apro from CVB4 or HRV2
resulted in cleavage of eIF4G, thus demonstrating direct
catalysis of eIF4G by 2Apro can occur (Lamphear et al.,
1993; Liebig et al., 1993). The aim of this study was to
examine whether eIF4G could serve as a substrate for
PV 2Apro and to determine whether PV and CVB 2Apro
FIG. 3. (A) Efficiency of direct cleavage on purified eIF4G by 2Apro. (A) Purified PV 2Apro and eIF4G-containing substrates used in reactions. 12.5%
SDS–PAGE gels stained with Coomassie brilliant blue or 7% SDS–PAGE silver-stained gels are shown for different preparations of PV 2Apro or eIF4G
substrates, respectively. Eight polypeptide constituents of eIF3 are identified on the right. Lanes a–e contain approximately 5, 5, 12, 0.28, and 0.88
mg protein, respectively. (B) Efficiency of direct cleavage of eIF4G in the eIF4F complex. Approximately 1 pmol (210 ng) of human eIF4G in the form
of an eIF4F complex was tested as substrate for direct cleavage by dilutions of purified 2Apro (pool C) as described under Materials and Methods.
Cleavage reactions were analyzed on 8% SDS–PAGE followed by silver stain. Amounts of 2Apro (in pmol) included in each reaction are indicated at
the top of each lane. Migration of eIF4G N-terminal (cpN) or C-terminal (cpC) cleavage products are indicated on the right and the asterisk denotes
a polypeptide which binds anti-eIF4G serum and copurifies with some preparations of eIF4F. (C) Efficiency of direct cleavage of eIF4G in the
eIF4F/eIF3 complex. Similar experimental conditions were used except that 2Apro pool S was used to cleave eIF4F/eIF3 complexes and cleavage
reactions were analyzed on a 7% gel. eIF4G cleavage products and eIF3 constituents are identified on the right. (D) Efficiency of direct cleavage of
eIF4G in the eIF4F/eIF3 complex by CVB4 2Apro. Reactions were identical to those described in C except that CVB4 2Apro was used.
TABLE 2
Percent Cleavage of Various Forms of eIF4G Substrates
Protease sample
Human eIF4F, molar ratio Human eIF4F/eIF3, molar ratio Rabbit eIF4F/eIF3, molar ratio
1:40 1:4 2.5:1 25:1 1:40 1:4 2.5:1 25:1 1:40 1:4 2.5:1 25:1
PV 2A pool S 2 0 35 91 0 4 52 97 0 4 19 45
PV 2A pool C 0 3 47 97 3 0 65 95 ND ND ND ND
PV 2A-His 2 1 5 14 ND ND ND ND ND ND ND ND
CVB4 2A 0 5 35 70 0 8 61 76 0 0 17 60
Note. Amounts of eIF4G cleavage in reactions carried out as described under Materials and Methods were determined using NIH Image and the
results of two experiments averaged. ND, not determined.
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were comparably efficient enzymes when tested under
the same experimental conditions.
Using highly active, recombinant protease and purified
eIF4G, we have shown that human or rabbit eIF4G can
serve as a substrate for PV 2Apro in direct cleavage
reactions. This is the first demonstration of direct eIF4G
cleavage by PV 2Apro in vitro. Significantly, in contrast to
the rapid and efficient cleavage activity of 1 nM 2Apro on
the virus-derived 1D2A peptide, both eIF4G-derived pep-
tides and eIF4G itself were found to be relatively poor
substrates of PV 2Apro in these reactions, requiring 250-
to 830-fold higher concentrations and molar excess of
2Apro to catalyze greater than 80% cleavage of eIF4G in
vitro. Furthermore, cleavage efficiencies of PV 2Apro and
CVB4 2Apro were similar in direct cleavage assays per-
formed on eIF4G substrates under equivalent experi-
mental conditions. This strongly suggests that PV and
CVB4 2A proteases are functionally equivalent in their
recognition of eIF4G as a substrate and implies that PV
and CVB are likely to utilize the same mechanism(s) to
cause eIF4G cleavage in vivo.
For direct cleavage assays of eIF4G, we also tested
the eIF4F/eIF3 complex as a substrate based on earlier
results suggesting that eIF3 was required for efficient
cleavage of eIF4G in mixtures containing crude PV 2Apro
and partially purified eIF4G (Wyckoff et al., 1990). Simi-
larly, eIF3 enhanced eIF4G cleavage catalyzed by a cel-
lular activity which migrated with a molecular mass near
55 kDa (Wyckoff et al., 1992). Here, the presence of eIF3
was not found to enhance the cleavage efficiency of PV
2Apro on eIF4G substrates; thus, earlier enhancement of
cleavage attributed to eIF3 may have been due to other
unknown factors present in those reactions. Recent stud-
ies using HRV2 2Apro have shown that eIF4G alone is a
much poorer substrate than eIF4G complexed with eIF4E
(in eIF4F) (Haghighat et al., 1996; Ohlmann et al., 1997). In
one study, the high molar ratios of HRV 2Apro required to
cleave eIF4F substrate were nearly identical to those
reported here for PV 2Apro (Haghighat et al., 1996). These
authors also tested the PV 2Apro pool S preparation used
in this study and found that direct cleavage of eIF4G
alone was much poorer than when complexed with
eIF4E (N. Sonenberg, personal communication). Thus,
the overall pattern of cleavage efficiencies among 2A
proteases of HRV2, CVB4, and PV appears to be very
similar on the various forms of eIF4G substrate. Each
2Apro cleaves the eIF4G found in eIF4F or eIF4F/eIF3
complexes with comparably low efficiency, and cleavage
is reduced about 100-fold further when eIF4G alone is
used as substrate.
These results have implications for the mechanism of
eIF4G cleavage which occurs in enterovirus-infected
cells. Based on the observations reported here, it is
possible that eIF4G in infected cells is cleaved directly
by PV 2Apro, as has been suggested for CVB and HRV, or
that both direct and indirect cleavage mechanisms op-
erate simultaneously. Thus it is important to determine
which mechanism is dominant in enterovirus- and rhino-
virus-infected cells. In this regard, our observations of
inefficient eIF4G cleavage in vitro must be reconciled
with the efficient and rapid cleavage of eIF4G seen in
vivo. Although 2Apro may reach higher concentrations in
certain subcellular microenvironments, eIF4G is a rela-
tively abundant cellular protein which, in the case of PV,
CVB, and HRV infection, is completely cleaved before
viral protein synthesis is detectable (Bonneau and
Sonenberg, 1987; Etchison et al., 1982; Kirchweger et al.,
1994). Taken together with the relatively inefficient direct
cleavage of eIF4G by purified proteases, this evidence
suggests that a more efficient mechanism for eIF4G
cleavage may exist in vivo. Numerous examples of viral
processes involving cellular factors exist in which cellu-
lar proteins are modified upon infection with certain
picornaviruses, and these proteins have been found to
participate in virus RNA replication as well as virus
translation (Andino et al., 1993; Belsham and Sonenberg,
1996; Roehl and Semler, 1995; Todd et al., 1995). One
hypothesis is that both the inefficient direct cleavage of
eIF4G by these viral proteases and a more efficient
cleavage mechanism involving a cellular factor are op-
erative simultaneously. Variable levels of critical cellular
factors among different types of cells may also provide
an explanation for the lack of host shutoff and incomplete
eIF4G cleavage observed in PV-infected ethrythroblas-
toid cells which contain high levels of 2Apro (Benton et
al., 1995). Accumulating evidence suggests that multiple
mechanisms, including activation of a cellular protease
FIG. 4. Analysis of poliovirus 2Apro-mediated cleavage of in vitro
translated eIF4Gwt and eIF4GG486E. mRNAs encoding eIF4Gwt and
eIF4GG486E were transcribed and translated in vitro as described under
Materials and Methods. Translation reactions (6 ml) were then incu-
bated in the presence of the indicated amount of PV 2Apro. Aliquots
were taken at 20 min and were subjected to SDS–PAGE on 7% gels.
Autoradiograms (insets) were scanned and the results presented in the
bar graphs. The positions of intact eIF4G translation product (4G) and
cleavage products (cpN and cpC) are indicated.
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which could amplify eIF4G cleavage, may be used by
entero- and rhinoviruses for efficient in vivo cleavage. A
resolution of the relative importance of these pathways
in the shutoff of host cell translation will require the
identification of the putative cellular factor(s) involved.
MATERIALS AND METHODS
Expression and purification of recombinant poliovirus-
2Apro and coxsackievirus 2Apro
Escherichia coli strain DH5a was transformed with the
plasmid pATH-2A (Wyckoff et al., 1990) or the control
plasmid pATH-11. pATH-2A contains the entire poliovirus
type 1 (Mahoney strain) 2A gene plus five upstream
poliovirus codons to provide the native 1D2A cleavage
site context, fused in-frame with the E. coli trpE gene,
whereas pATH-11 lacks the 2A sequence. Stationary
phase cultures were diluted 1:75 into M9 minimal me-
dium and grown at 16°C to an A600 of 0.4 before induc-
tion of the trp operon by the addition of 3-b-indoleacrylic
acid (10 mg/ml). Induced expression continued at 16°C to
an A600 of 0.8. Bacteria were harvested by centrifugation,
resuspended in buffer S (10 mM Mops, pH 7.2, at 4°C, 1.2
mM MgOAc, 10 mM KCl, 1 mM EDTA, and 0.3% Brij 35),
and lysed in a French Pressure Cell followed by 4 3 30 s
sonication bursts on ice to further disrupt protein aggre-
gates. Bacterial cell lysates were centrifuged for 10 min
at 10,000g and proteins were precipitated from the sol-
uble fraction (S10) by addition of a saturated solution of
ammonium sulfate to a final concentration of 40%. The
precipitated fraction was harvested by centrifugation for
15 min at 10,000g and resuspended in buffer M (20 mM
Tris–HCl, pH 8, 1 mM EDTA, 7 mM 2-ME, 5 mM ZnCl2, 5%
glycerol, and 0.03% Brij 35) containing 25 mM NaCl.
Remaining insoluble proteins were removed by centrifu-
gation for 10 min at 23,000g prior to separation on an
MA7Q anion exchange column (100 3 19 mm, Bio-Rad)
equilibrated in the same buffer. Bound proteins were
eluted in a 25 mM to 1 M NaCl gradient. Fractions
containing the greatest amount of 2Apro were pooled and
further enriched for 2Apro by differential centrifugation at
100,000g. The insoluble fraction was resuspended in
buffer M and sedimented a second time at 100,000g. The
new soluble fraction (S100) was then concentrated 10-
fold by dialysis against solid PEG8000 to yield an enriched
(277-fold) 2Apro (pool S) used in experimental assays.
Alternatively, ammonium sulfate precipitated 2Apro was
resuspended in buffer A (20 mM Tris–HCl, pH 8.0, 100
mM NaCl, 0.5 mM EDTA, 5% glycerol, 7 mM 2-ME) and
chromatographed over a Sephacryl S300 column (12 3
2.4 cm). The majority of 2Apro eluted in the high-molec-
ular-weight fraction; however, a small proportion (ap-
proximately 2%) was significantly delayed and eluted
after both excluded and included protein fractions had
been collected. This fraction contained no other contam-
inating proteins and was concentrated approximately
50-fold in a Centricon concentrator (pool C).
The 2Apro gene was also amplified by PCR using
primers with internal restriction sites and cloned into the
vector pET-22b1 previously linearized with BamHI and
EcoRI (Novagen). The resulting plasmid (ppelB2A-his)
expressed 2Apro as a fusion product containing an ami-
no-terminal pelB leader sequence and a carboxyl-termi-
nal polyhistidine sequence and was transformed into E.
coli strain BLR(DE3)plysS. Cells were grown in LB media
until the optical density reached 0.6, then IPTG was
added to 0.5 mM final concentration. Cells were grown at
30°C for an additional 4 h before being harvested. Cells
were lysed as described above, then P10 pellets which
contained the majority of 2A-his were solubilized with 7
M urea in TMO buffer, then affinity purified over a Talon-
chelate column (Clontech), and renatured essentially as
described previously (Yalamanchili et al., 1997).
Total protein concentration was measured using the
method of Bradford (Bio-Rad), and 2Apro concentration
was determined by comparison with several other pro-
tein standards on Coomassie-stained SDS–PAGE gels.
CVB4 2Apro was expressed and purified as previously
described (Liebig et al., 1993).
Purification of eIF4G protein
The eIF4F/eIF3 complex was purified by m7GTP–
Sepharose (Pharmacia LKB) affinity chromatography
(Lamphear and Panniers, 1990). Briefly, the ribosomal
salt wash fraction from uninfected HeLa cells, or from
rabbit reticulocyte lysate obtained from Green Hectares
(Oregon, WI), was twice passed over a 1-ml column of
the Sepharose matrix, and unbound proteins were
washed from the column with a low salt buffer. Specifi-
cally bound eIF4F/eIF3 complex was eluted with 70 mM
m7GTP (Sigma-Aldrich). eIF4F complex was obtained by
sedimentation of HeLa ribosomal salt wash through a
10–30% sucrose gradient containing high salt as de-
scribed previously (Etchison and Smith, 1990). Gradient
fractions containing only eIF4F were then further purified
over m7GTP–Sepharose as described above. Purified
eIF4G in complexes was quantitated by comparison with
dilutions of protein standards on Coomassie brilliant
blue-stained SDS–PAGE gels and UV adsorption.
Direct cleavage assays on protein substrates
Reactions using the purified eIF4F/eIF3 complex for
the substrate were carried out for 120 min at 30°C in a
100-ml final volume. Each reaction contained approxi-
mately 220 ng of eIF4G substrate and 0.05 to 500 ng
2Apro. Similar reactions using eIF4F were carried out in a
30-ml volume using approximately 200 ng of eIF4G sub-
strate. Reaction buffer contained 100 mM NaCl, 1 mM
MgCl2, 0.4 mM 2-mercaptoethanol, and 5% glycerol. After
incubation, protein samples were boiled in gel loading
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buffer (43 stock consisting of 26 mM DTT, 60 mM Tris–
HCl at pH 6.8, 40% glycerol, 6% SDS) and separated on 7
or 8% SDS–PAGE gels. eIF4G or its cleavage products
were visualized by silver staining or immunoblotting
(Lloyd et al., 1987; Morrisey, 1981). The extent of cleavage
was determined for PV by using the image analysis
program NIH Image to compare the intensity of product
and intact protein bands from scans of silver-stained
gels.
Direct cleavage assays on peptide substrates
Peptide cleavage reactions were carried out essen-
tially as described previously (Sommergruber et al.,
1989). Briefly, each 30-ml reaction was carried out for 90
min at 30°C in the same reaction buffer as described
above and contained 2 to 20 mg of peptide substrate and
0.5–5.0 mg of 2Apro. Proteins were precipitated by addi-
tion of trichloroacetic acid to 10% and centrifuged. The
pH of the peptide-containing supernate was neutralized
by addition of K2HPO4 to 840 mM prior to analysis by
reverse-phase chromatography. Samples were loaded
onto a C-18 Ultrasphere column (Beckman) equilibrated
in buffer A (0.08% trifluoracetic acid in ultrapure water);
bound peptides were eluted in a 0–40% gradient of buffer
B (0.05% trifluoracetic acid in acetonitrile) and detected
by absorbance at 214 nm. Amounts of intact peptides and
their cleavage products were quantitated by measure-
ment of peak areas with Dynamax HPLC analysis soft-
ware (Rainin).
Analysis of poliovirus 2Apro-mediated cleavage
of eIF4Gwt and eIF4GG486E
For analysis of 35S-labeled eIF4G, mRNAs encoding
eIF4Gwt and eIF4GG486E were transcribed from the XhoI-
linearized plasmids pAD4Gwt and pAD4GG486E, respec-
tively, and translated in vitro as described previously
(Lamphear and Rhoads, 1996). Translation reactions (6
ml) were then incubated with the indicated amounts of
poliovirus 2Apro at 30°C. After 20 min, aliquots were
removed and subjected to SDS–PAGE followed by auto-
radiography.
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